Evaluación ecocardiográfica de la función diastólica del VI en el adulto. 📄Diagnostics 2026. 💯
🟠La valoración diastólica del VI sigue siendo un pilar de la ecocardiografía integral. No solo estima presiones de llenado, sino que es clave en el estudio de la IC FEVI preservada.
🔎 Enfoque actual multiparamétrico➡️ No existe un solo parámetro definitivo. La recomendación es integrar mediciones “clásicas” + técnicas avanzadas, adaptadas al contexto clínico y comorbilidades. 🤔⤵️
🟠Parámetros primarios:
▪️Flujo mitral (E, A, E/A, DT).
▪️Doppler tisular (e’, E/e’).
▪️Flujo venoso pulmonar (S, D, ar).
▪️TR e IVRT.
▪️Volumen auricular izquierdo indexado (LAVi).
▪️GLS del VI.
⚠️Disfunción si: E/e’ >14, LAVi >34 ml/m², TR elevada (>2.8 m/s) y e’ reducido orientan a ⤴️presiones de llenado.
🟠Técnicas avanzadas:
▪️Strain auricular (LARS)➡️ fuerte valor pronóstico en FE preservada.
▪️Myocardial Work (MW)➡️ puede aportar información indirecta sobre disfunción diastólica.
▪️Time-Harmonic Elastography (THE)➡️ nueva herramienta para rigidez miocárdica.
⚠️Limitaciones relevantes: edad, carga, arritmias, ventana acústica, variabilidad inter-vendor y dependencia del operador siguen siendo retos importantes.
📄🆓️⤵️
https://t.co/L3f77M9oeQ
https://t.co/DgkMutQpGe
Moderate consumption of caffeinated coffee or tea was linked to reduced #dementia risk and modest improvements in cognitive outcomes; no benefit was seen for decaffeinated coffee in an observational study of US adults.
https://t.co/jlPgjAuosa
🫀 Myocarditis & Pericarditis: a new era is here!
The 2025 ESC Guidelines and latest ACC position papers mark a turning point in inflammatory heart disease 🔄
✨ What’s new?
📌 CMR as the non-invasive gold standard
📌 Less biopsy, more precision
📌 IL-1 blockade changing recurrent pericarditis care
📌 From “one-size-fits-all” to risk- and phenotype-driven management
🔍 Different frameworks (ESC certainty tiers vs ACC staging), same direction:
👉 earlier diagnosis
👉 targeted therapy
👉 personalised follow-up
🚀 The future is imaging-driven, multidisciplinary, and patient-centred
#Myocarditis #Pericarditis #ESCguidelines #ACC #CMR #CardioImaging #InflammatoryHeartDisease #PrecisionCardiology #IL1 #Cardiology #MedTwitter #CardioTwitter
DOI: 10.1016/j.jacc.2025.10.047
🧵 Why can oxygen worsen respiratory failure in COPD?
Many clinicians still fear giving oxygen to COPD patients.
The reason they’re taught?
"Loss of hypoxic drive"
But this is mostly a myth.
Here’s what really causes oxygen-induced hypercapnia 👇
DYSLIPIDEMIA MANAGEMENT 2026
✍️JUST PULBISHED BY @ClinMedJournals:
✍️Practical guide to the management of dyslipidaemia
✍️Very nicely written review on traditional and newcommer agents on lipid-lowering therapy
https://t.co/YBXBG2ZnOe
#pelacarsen#evinacumab#muvalapin#olezarsen
Meta-analysis of four randomized trials found β-blockers did not reduce mortality, recurrent #MyocardialInfarction (MI), heart failure, or revascularization in patients with preserved left ventricular ejection fraction after MI. https://t.co/7Kht1Pi1QE
New publication from the Cardiology Experts Team at The Meta-Analysis Academy, and it’s in JACC! Congratulations to Nelson, Guilherme, and all collaborators.
It’s truly rewarding to see The Meta-Analysis Academy alumni achieving such great success!
https://t.co/Cj7fF94oJc
#Cardiology #JACC #MedTwitter